Profil
Nicholas Shubin currently works at NemaGen Discoveries, Inc., as Chief Executive Officer from 2022.
Postes actifs de Nicholas Shubin
Sociétés | Poste | Début |
---|---|---|
Nemagen Discoveries, Inc.
Nemagen Discoveries, Inc. Miscellaneous Commercial ServicesCommercial Services NemaGen Discoveries, Inc. is a biotech company located in Princeton, NJ. The company focuses on developing therapies for patients with allergic inflammation and mast cell-related diseases. NemaGen's unique approach to drug development involves investigating the body's natural ability to prevent unwanted inflammation following parasitic infections. Recently, NemaGen announced its participation in the NIH I-Corps program to better understand stakeholders' needs and validate the value of its therapies. The company was founded by Mark Siracusa and has been led by CEO Nicholas Shubin since 2022. | Directeur Général | 01/09/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Nemagen Discoveries, Inc.
Nemagen Discoveries, Inc. Miscellaneous Commercial ServicesCommercial Services NemaGen Discoveries, Inc. is a biotech company located in Princeton, NJ. The company focuses on developing therapies for patients with allergic inflammation and mast cell-related diseases. NemaGen's unique approach to drug development involves investigating the body's natural ability to prevent unwanted inflammation following parasitic infections. Recently, NemaGen announced its participation in the NIH I-Corps program to better understand stakeholders' needs and validate the value of its therapies. The company was founded by Mark Siracusa and has been led by CEO Nicholas Shubin since 2022. | Commercial Services |